Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-071784
Filing Date
2010-08-03
Accepted
2010-08-03 16:10:51
Documents
11
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a56182e10vq.htm 10-Q 878177
2 EX-15.1 a56182exv15w1.htm EX-15.1 3579
3 EX-15.2 a56182exv15w2.htm EX-15.2 1699
4 EX-31.1 a56182exv31w1.htm EX-31.1 5408
5 EX-31.2 a56182exv31w2.htm EX-31.2 5415
6 EX-32 a56182exv32.htm EX-32 2812
  Complete submission text file 0000950123-10-071784.txt   4862041

Data Files

Seq Description Document Type Size
7 EX-101 INSTANCE DOCUMENT vrx-20100630.xml EX-101.INS 897917
8 EX-101 SCHEMA DOCUMENT vrx-20100630.xsd EX-101.SCH 19103
9 EX-101 CALCULATION LINKBASE DOCUMENT vrx-20100630_cal.xml EX-101.CAL 60767
10 EX-101 LABELS LINKBASE DOCUMENT vrx-20100630_lab.xml EX-101.LAB 180320
11 EX-101 PRESENTATION LINKBASE DOCUMENT vrx-20100630_pre.xml EX-101.PRE 100473
Mailing Address ONE ENTERPRISE ALISO VIEJO CA 92656
Business Address ONE ENTERPRISE ALISO VIEJO CA 92656 949-461-6000
VALEANT PHARMACEUTICALS INTERNATIONAL (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-11397 | Film No.: 10987755
SIC: 2834 Pharmaceutical Preparations